4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells

被引:38
作者
Barrera, G
Pizzimenti, S
Serra, A
Ferretti, C
Fazio, VM
Saglio, G
Dianzani, MU
机构
[1] UNIV TURIN,DIPARTIMENTO ANAT FARMACOL & MED LEGALE,TURIN,ITALY
[2] UNIV TURIN,OSPED SAN LUIGI GONZAGA,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,TURIN,ITALY
[3] UNIV CATTOLICA SACRO CUORE,IST PATOL GEN,ROME,ITALY
关键词
D O I
10.1006/bbrc.1996.1550
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
4-Hydroxynonenal, an aldehyde produced from lipid peroxidation of cellular membranes, inhibits growth and induces differentiation of HL-60 human leukemic cell line. Since it is highly unstable in the culture medium, its effectiveness is increased when added repeatedly to the cell suspension. we have previously demonstrated that HNE inhibits c-myc but not N-ras expression in HL-60 cells. Here we investigate its effect on the expression of c-myb and c-fos, two early genes involved in the induction of myeloid and monocytic differentiation. Moreover, since c-fos is directly correlated with the intracellular level of cAMP, we also analysed the cAMP concentration after aldehyde treatment. HNE significantly inhibits c-myb expression during and after repeated treatments. A single administration of 1 mu M HNE decreases c-myb mRNA at 1 hour whereas 10 mu M HNE inhibits c-myb expression from 3 to 6 hours after treatment, and then the expression returns to the control level. By contrast, c-fos expression and intracellular cAMP concentration do not show any significant change after HNE treatments. (C) 1996 Academic Press, Inc.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 22 条
  • [1] THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION
    ANGEL, P
    KARIN, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) : 129 - 157
  • [2] INHIBITION OF C-MYC EXPRESSION INDUCED BY 4-HYDROXYNONENAL, A PRODUCT OF LIPID-PEROXIDATION, IN THE HL-60 HUMAN LEUKEMIC-CELL LINE
    BARRERA, G
    MURACA, R
    PIZZIMENTI, S
    SERRA, A
    ROSSO, C
    SAGLIO, G
    FARACE, MG
    FAZIO, VM
    DIANZANI, MU
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (01) : 553 - 561
  • [3] BARRERA G, 1991, EXP CELL RES, V197, P149
  • [4] INVOLVEMENT OF COMMON AND CELL TYPE-SPECIFIC PATHWAYS IN C-FOS GENE-CONTROL - STABLE INDUCTION BY CAMP IN MACROPHAGES
    BRAVO, R
    NEUBERG, M
    BURCKHARDT, J
    ALMENDRAL, J
    WALLICH, R
    MULLER, R
    [J]. CELL, 1987, 48 (02) : 251 - 260
  • [5] BUSCHER M, 1988, ONCOGENE, V3, P301
  • [6] STAGE-RELATED PROLIFERATIVE ACTIVITY DETERMINES C-MYB FUNCTIONAL REQUIREMENTS DURING NORMAL HUMAN HEMATOPOIESIS
    CARACCIOLO, D
    VENTURELLI, D
    VALTIERI, M
    PESCHLE, C
    GEWIRTZ, AM
    CALABRETTA, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) : 55 - 61
  • [7] LIPID-PEROXIDATION AND CANCER
    DIANZANI, MU
    [J]. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1993, 15 (02) : 125 - 147
  • [8] DIANZANI MU, 1982, FREE RADICALS LIPID, P129
  • [9] CHEMISTRY AND BIOCHEMISTRY OF 4-HYDROXYNONENAL, MALONALDEHYDE AND RELATED ALDEHYDES
    ESTERBAUER, H
    SCHAUR, RJ
    ZOLLNER, H
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) : 81 - 128
  • [10] GOLAY J, 1991, BLOOD, V77, P149